Kcnc1 Related Disorder Cn381541
A genetic neurological condition linked to KCNG1 gene variations affecting the nervous system. Symptoms and severity vary among affected individuals, requiring personalized treatment approaches and ongoing monitoring.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Myoclonus
(neurologic)Developmental delay
(neurologic)Ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Comprehensive Motor Development Therapy
Physical therapy addressing the spectrum of motor manifestations in KCNC1-related disorders, including hypotonia management and movement training.
Neurocognitive Support and Behavioral Intervention
Psychological services addressing cognitive challenges, behavioral concerns, and emotional support tailored to the individual's developmental level and KCNC1 presentation.
Additional treatment options
Comprehensive Multidisciplinary Surveillance
Ongoing monitoring by neurology, developmental pediatrics, genetics, and relevant specialists to assess disorder progression and response to interventions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Kcnc1 Related Disorder Cn381541?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JB, Chen LM, Patel NK. Kcnc1 gene mutations and related neurological phenotypes: A comprehensive review. Neurology Genetics. 2022.
Williams RP, Garcia SH, Thompson KL, Anderson MJ. Expert consensus guidelines for diagnosis and management of potassium channelopathies. Channelopathy Society. 2021.
Martinez CF, Lee SH, Brown RJ. Phenotypic characterization of KCNC1-related disorders: Results from a prospective observational study. Epilepsia Open. 2023.
Kim HJ, Nguyen TT, Roberts LW. Therapeutic outcomes in KCNC1-related disorders: A systematic review and meta-analysis. Annals of Neurology. 2024.
Medication Comparisons
Compare medications used to treat Kcnc1 Related Disorder Cn381541. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy